Personalized medicine can pave the way for the safe use of CB₁ receptor antagonists.

Lazary, Judit

Personalized medicine can pave the way for the safe use of CB₁ receptor antagonists. [electronic resource] - Trends in pharmacological sciences May 2011 - 270-80 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

1873-3735

10.1016/j.tips.2011.02.013 doi


Animals
Anti-Obesity Agents--adverse effects
Genetic Testing--methods
Humans
Obesity--drug therapy
Piperidines--adverse effects
Polymorphism, Genetic
Precision Medicine--methods
Pyrazoles--adverse effects
Receptor, Cannabinoid, CB1--antagonists & inhibitors
Rimonabant
Substance-Related Disorders--drug therapy